We have found that another effect of increased Src signaling in metastatic melanoma cells is to suppress RhoA activity, through Src-dependent phosphorylation and activation of one of Rho's negative regulators, p190RhoGAP. The gene discussed is ARHGAP35; the disease is metastatic melanoma.